Agilent Technologies, a life science CDMO and laboratory product developer, is laying off 184 staffers across six locations in California. The company previously said it had restructuring plans this year.
Agilent offers oligonucleotide peptide manufacturing and laboratory management products such as chromatography and mass spectrometry devices. It was spun off from Hewlett-Packard in 1999.
The bulk of the cuts (156 employees) are at the company’s headquarters in Santa Clara, CA. The other 28 staffers are spread out from various locations: one in Sacramento, two sites in San Diego, and another two sites in Santa Barbara, according to a WARN notice. The layoffs will be effective in August.
Agilent in December said it plans to cut around 400 workers in the first quarter of 2024, according to an SEC filing. But it is unclear if this month’s cuts are separate from that previous announcement.
In December last year, Agilent said it had around 18,100 employees with 6,900 of them in the US in October, as per its 2023 annual report. The company had also cut nearly 70 employees in December 2023 in San Diego and Santa Clara, according to the WARN website.
The company’s revenue declined to $1.66 billion in the first quarter of 2024, down 5.6% compared to the same period last year. Revenues from its life science and diagnostic business units took a hit although its lab management services increased its revenue by 6%.
Last year, Agilent reported steady 2023 revenues of $6.83 billion versus $6.84 billion in 2022.
Editor’s note: The headline was corrected to note that the company is not just a CDMO.